{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:36:38Z","timestamp":1787988998445,"version":"build-2784847793"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1A2C2004696"],"award-info":[{"award-number":["2021R1A2C2004696"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022M3A9B6017654"],"award-info":[{"award-number":["2022M3A9B6017654"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1A4A1021787"],"award-info":[{"award-number":["2021R1A4A1021787"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1C1C1009320"],"award-info":[{"award-number":["2021R1C1C1009320"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jconrel.2024.09.029","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T10:01:36Z","timestamp":1727085696000},"page":"574-588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Laser-responsive erastin-loaded chondroitin sulfate nanomedicine targeting CD44 and system xc\u2212 in liver cancer: A non-ferroptotic approach"],"prefix":"10.1016","volume":"375","author":[{"given":"So-Yeol","family":"Yoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Seob","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang Mo","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hoon","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seokjin","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Chan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang Su","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Jun","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Duk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Jin","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Kyum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keon Wook","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2023","key":"10.1016\/j.jconrel.2024.09.029_bb0005","first-page":"17","article-title":"Cancer statistics","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0010","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular Carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0015","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41419-023-06264-3","article-title":"MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function","volume":"14","author":"Li","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12072-021-10278-4","article-title":"Patients with polyclonal hepatocellular carcinoma are at a high risk of early recurrence and have a poor recurrence-free survival period","volume":"16","author":"Kaibori","year":"2022","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0025","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.23725","article-title":"Loco-regional treatment of hepatocellular carcinoma","volume":"52","author":"Lencioni","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2024.09.029_bb0030","first-page":"8157406","article-title":"Diagnosis, therapy, and prognosis for hepatocellular carcinoma","volume":"2020","author":"Ren","year":"2020","journal-title":"Anal. Cell. Pathol. (Amst.)"},{"key":"10.1016\/j.jconrel.2024.09.029_bb0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jconrel.2024.09.029_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15948-3","article-title":"Immune modulation by molecularly targeted photothermal ablation in a mouse model of advanced hepatocellular carcinoma and cirrhosis","volume":"12","author":"Munoz","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0045","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jhep.2019.08.035","article-title":"Targeting Jak\/stat pathway as a therapeutic strategy against SP\/CD44+tumorigenic cells in Akt\/\u03b2-catenin-driven hepatocellular carcinoma","volume":"72","author":"Toh","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0050","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0055","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41571-020-0396-9","article-title":"Combination set to transform HCC therapy","volume":"17","author":"Romero","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0060","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/s12276-022-00864-3","article-title":"Molecular targeted therapy for anticancer treatment","volume":"54","author":"Min","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-021-00572-w","article-title":"Small molecules in targeted cancer therapy: advances, challenges, and future perspectives","volume":"6","author":"Zhong","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40005-022-00607-6","article-title":"Nanomedicine-based commercial formulations: current developments and future prospects","volume":"53","author":"Thapa","year":"2023","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0075","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2011.01.038","article-title":"CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(\u2212) and thereby promotes tumor growth","volume":"19","author":"Ishimoto","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2024.09.029_bb0080","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/ncomms1892","article-title":"Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell","volume":"3","author":"Yae","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0085","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.2147\/CMAR.S175681","article-title":"CD44 is overexpressed and correlated with tumor progression in gallbladder cancer","volume":"10","author":"He","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0090","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13045-018-0605-5","article-title":"The biology and role of CD44 in cancer progression: therapeutic implications","volume":"11","author":"Chen","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0095","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.ccell.2018.05.003","article-title":"Liver Cancer initiation requires p53 inhibition by CD44-enhanced growth factor signaling","volume":"33","author":"Dhar","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2024.09.029_bb0100","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1158\/0008-5472.CAN-12-0299","article-title":"CD44s regulates the TGF-\u03b2-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma","volume":"72","author":"Mima","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.873","article-title":"CD44 is involved in liver regeneration through enhanced uptake of extracellular cystine","volume":"12","author":"Kim","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0110","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41420-022-01297-7","article-title":"Recent progress in ferroptosis: inducers and inhibitors","volume":"8","author":"Du","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0115","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2024.09.029_bb0120","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.tcb.2020.02.009","article-title":"Emerging mechanisms and disease relevance of Ferroptosis","volume":"30","author":"Stockwell","year":"2020","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0125","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0135","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1002\/adfm.201500680","article-title":"Phenylboronic acid-decorated chondroitin sulfate A-based theranostic nanoparticles for enhanced tumor targeting and penetration","volume":"25","author":"Lee","year":"2015","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0140","article-title":"Bone tumor-homing nanotherapeutics for prolonged retention in tumor microenvironment and facilitated apoptotic process via mevalonate pathway inhibition","volume":"19","author":"Kang","year":"2023","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2024.09.029_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.117187","article-title":"Chondroitin sulfate-hybridized zein nanoparticles for tumor-targeted delivery of docetaxel","volume":"253","author":"Lee","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0150","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3892\/mmr.2021.12352","article-title":"Erastin-induced ferroptosis causes physiological and pathological changes in healthy tissues of mice","volume":"24","author":"Zhao","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0155","doi-asserted-by":"crossref","first-page":"8185","DOI":"10.7150\/thno.59121","article-title":"Designer exosomes for targeted and efficient ferroptosis induction in cancer via chemo-photodynamic therapy","volume":"11","author":"Du","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2024.09.029_bb0160","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ejpb.2015.06.011","article-title":"Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery","volume":"94","author":"Lee","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115568","article-title":"Blood component ridable and CD44 receptor targetable nanoparticles based on a maleimide-functionalized chondroitin sulfate derivative","volume":"230","author":"Lee","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.117459","article-title":"Chondroitin sulfate-based nanoparticles for enhanced chemo-photodynamic therapy overcoming multidrug resistance and lung metastasis of breast cancer","volume":"254","author":"Shi","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0175","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s40005-022-00583-x","article-title":"A comprehensive review on different approaches for tumor targeting using nanocarriers and recent developments with special focus on multifunctional approaches","volume":"52","author":"Sahu","year":"2022","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114339","article-title":"Materials and device design for advanced phototherapy systems","volume":"186","author":"Seung Lee","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175421","article-title":"Nanoparticles and phototherapy combination as therapeutic alternative in prostate cancer: a scoping review","volume":"939","author":"Ferreira","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0190","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4329\/wjr.v9.i3.91","article-title":"Laser ablation of liver tumors: an ancillary technique, or an alternative to radiofrequency and microwave?","volume":"9","author":"Sartori","year":"2017","journal-title":"World J. Radiol."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0195","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s40005-021-00553-9","article-title":"Lipid-based nanoparticles for photosensitive drug delivery systems","volume":"52","author":"Shim","year":"2022","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0200","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.1016\/j.biomaterials.2012.04.044","article-title":"Indocyanine green-loaded biodegradable tumor targeting nanoprobes for in vitro and in vivo imaging","volume":"33","author":"Zheng","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.09.029_bb0205","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jso.21943","article-title":"The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery","volume":"104","author":"Schaafsma","year":"2011","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0210","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s40005-022-00594-8","article-title":"Progress and recent trends in photodynamic therapy with nanoparticles","volume":"52","author":"Rhew","year":"2022","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0215","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.4155\/fmc.14.86","article-title":"The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer","volume":"6","author":"Bonner","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0220","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40824-022-00276-4","article-title":"Surface-mediated high antioxidant and anti-inflammatory effects of astaxanthin-loaded ultrathin graphene oxide film that inhibits the overproduction of intracellular reactive oxygen species","volume":"26","author":"Chae","year":"2022","journal-title":"Biomater. Res."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0225","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","article-title":"Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging","volume":"97","author":"Jomova","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0230","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0235","article-title":"Gelatin nanofiber assisted zero order release of amphotericin-B: a study with realistic drug loading for oral formulation","volume":"24","author":"Gaydhane","year":"2020","journal-title":"Mater. Today Commun."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0240","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/s41598-020-80119-1","article-title":"Modified-release of encapsulated bioactive compounds from annatto seeds produced by optimized ionic gelation techniques","volume":"11","author":"Naranjo-Duran","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0245","article-title":"Biodegradable silk-curcumin composite for sustained drug release and visual wound monitoring","volume":"27","author":"Jaya Prakash","year":"2023","journal-title":"Mater. Today Chem."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0250","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12272-023-01438-1","article-title":"Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin","volume":"46","author":"Kim","year":"2023","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0255","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.fct.2018.12.035","article-title":"Short-term regulation of the hepatic activities of cytochrome P450 and glutathione S-transferase by nose-only cigarette smoke exposure in mice","volume":"125","author":"Ryu","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0260","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.4155\/tde.12.105","article-title":"Application of polysaccharides for surface modification of nanomedicines","volume":"3","author":"Doh","year":"2012","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0265","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jiec.2021.07.018","article-title":"Current developments in esterification reaction: a review on process and parameters","volume":"103","author":"Khan","year":"2021","journal-title":"J. Ind. Eng. Chem."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.progpolymsci.2020.101241","article-title":"Polymer bioconjugates: modern design concepts toward precision hybrid materials","volume":"105","author":"Chen","year":"2020","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0275","doi-asserted-by":"crossref","first-page":"230","DOI":"10.7150\/thno\/v01p0230","article-title":"Photosensitizer-conjugated human serum albumin nanoparticles for effective photodynamic therapy","volume":"1","author":"Jeong","year":"2011","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2024.09.029_bb0280","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.2147\/IJN.S155383","article-title":"Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment","volume":"13","author":"Song","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.09.029_bb0285","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jconrel.2024.03.046","article-title":"Tumor-targeted and stimulus-responsive polymeric prodrug nanoparticles to enhance the anticancer therapeutic efficacy of doxorubicin","volume":"369","author":"Kim","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.09.029_bb0290","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.addr.2010.03.011","article-title":"Tumor delivery of macromolecular drugs based on the EPR effect","volume":"63","author":"Torchilin","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2020.114426","article-title":"Effect of pH and surfactants on the electrokinetic properties of nanoparticles dispersions and their application to the PET fibres modification","volume":"320","author":"Kowalczyk","year":"2020","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0300","doi-asserted-by":"crossref","first-page":"13379","DOI":"10.1021\/acs.langmuir.1c02056","article-title":"Zeta potential and colloidal stability predictions for inorganic nanoparticle dispersions: effects of experimental conditions and electrokinetic models on the interpretation of results","volume":"37","author":"Pochapski","year":"2021","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2024.09.029_bb0305","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jconrel.2020.09.020","article-title":"Zero-order drug delivery: state of the art and future prospects","volume":"327","author":"Laracuente","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.09.029_bb0310","doi-asserted-by":"crossref","first-page":"30631","DOI":"10.1039\/C5RA01425E","article-title":"Anthraquinone chromophore covalently bonded blocked waterborne polyurethanes: synthesis and application","volume":"5","author":"Mao","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0315","doi-asserted-by":"crossref","first-page":"26032","DOI":"10.18632\/oncotarget.25430","article-title":"CD44 positive and sorafenib insensitive hepatocellular carcinomas respond to the ATP-competitive mTOR inhibitor INK128","volume":"9","author":"Badawi","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2024.09.029_bb0320","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1186\/1471-2407-14-722","article-title":"Cancer stem-like sphere cells induced from de-differentiated hepatocellular carcinoma-derived cell lines possess the resistance to anti-cancer drugs","volume":"14","author":"Hashimoto","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jconrel.2024.09.029_bb0325","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.colsurfb.2014.07.030","article-title":"Size-controlled biodegradable nanoparticles: preparation and size-dependent cellular uptake and tumor cell growth inhibition","volume":"122","author":"Choi","year":"2014","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2024.09.029_bb0330","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.apsb.2021.02.019","article-title":"Exploration and insights into the cellular internalization and intracellular fate of amphiphilic polymeric nanocarriers","volume":"11","author":"Mazumdar","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2024.09.029_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101328","article-title":"Insight into the mechanism of ferroptosis inhibition by ferrostatin-1","volume":"28","author":"Miotto","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0340","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.4103\/1673-5374.274344","article-title":"Neuroprotective effect of deferoxamine on erastininduced ferroptosis in primary cortical neurons","volume":"15","author":"Zhang","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0345","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/07315724.2006.10719547","article-title":"N-acetylcysteine partially reverses oxidative stress and apoptosis exacerbated by Mg-deficiency culturing conditions in primary cultures of rat and human hepatocytes","volume":"25","author":"Martin","year":"2006","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0350","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.biopsych.2019.12.008","article-title":"Innovations in clinical neuroscience: tools, techniques, and transformative frameworks","volume":"87","author":"Langenecker","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jconrel.2024.09.029_bb0355","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.apsb.2021.12.007","article-title":"Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1","volume":"12","author":"Luo","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2024.09.029_bb0360","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2022.05.024","article-title":"NAC alleviative ferroptosis in diabetic nephropathy via maintaining mitochondrial redox homeostasis through activating SIRT3-SOD2\/Gpx4 pathway","volume":"187","author":"Li","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2021.111497","article-title":"CopA3 peptide induces permanent cell-cycle arrest in colorectal cancer cells","volume":"196","author":"Dey","year":"2021","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0370","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/toxins10010024","article-title":"ROS-mediated cell cycle arrest and apoptosis induced by zearalenone in mouse sertoli cells via ER stress and the ATP\/AMPK pathway","volume":"10","author":"Zheng","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.jconrel.2024.09.029_bb0375","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.toxlet.2015.09.002","article-title":"Protective effects of the thiol compounds GSH and NAC against sulfur mustard toxicity in a human keratinocyte cell line","volume":"244","author":"Balszuweit","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0380","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.apsb.2018.12.004","article-title":"Hypocrellin A-based photodynamic action induces apoptosis in A549 cells through ROS-mediated mitochondrial signaling pathway","volume":"9","author":"Qi","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2024.09.029_bb0385","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bbrc.2021.12.033","article-title":"Role of photobleaching process of indocyanine green for killing neuroblastoma cells","volume":"589","author":"Clutter","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0390","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jconrel.2023.03.001","article-title":"Doxorubicin and erastin co-loaded hydroxyethyl starch-polycaprolactone nanoparticles for synergistic cancer therapy","volume":"356","author":"Xu","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.09.029_bb0395","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1172\/JCI9053","article-title":"Apoptosis and cancer drug targeting","volume":"104","author":"Sellers","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0400","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/21556660.2020.1857103","article-title":"Review of cyclin-dependent kinase 4\/6 inhibitors in the treatment of advanced or metastatic breast cancer","volume":"10","author":"Husinka","year":"2020","journal-title":"J. Drug Assess."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0405","first-page":"1913","article-title":"CDK inhibitors in cancer therapy, an overview of recent development","volume":"11","author":"Zhang","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0410","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1038\/s41598-022-08336-4","article-title":"Cell cycle arrest is an important mechanism of action of compound Kushen injection in the prevention of colorectal cancer","volume":"12","author":"Sun","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2024.09.029_bb0415","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1016\/j.apsb.2021.10.019","article-title":"A hybrid bacterium with tumor-associated macrophage polarization for enhanced photothermal-immunotherapy","volume":"12","author":"Zhao","year":"2022","journal-title":"Acta Pharm. Sin. B"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924006394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924006394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:20:12Z","timestamp":1762269612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924006394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":83,"alternative-id":["S0168365924006394"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.09.029","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laser-responsive erastin-loaded chondroitin sulfate nanomedicine targeting CD44 and system xc\u2212 in liver cancer: A non-ferroptotic approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}